Amgen Inc. (AMGN) Issues FY14 Earnings Guidance
Amgen Inc. (NASDAQ:AMGN) updated its FY14 earnings guidance on Tuesday. The company provided earnings per share guidance of $7.90-8.20 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $8.14, AnalystRatingsNetwork reports. The company issued revenue guidance of $19.2-19.6 billion, compared to the consensus revenue estimate of $19.58 billion.
Several analysts have recently commented on the stock. Analysts at Ned Davis Research upgraded shares of Amgen from a neutral rating to a buy rating in a research note to investors on Monday. On a related note, analysts at TheStreet reiterated a buy rating on shares of Amgen in a research note to investors on Tuesday, January 14th. Finally, analysts at Nomura initiated coverage on shares of Amgen in a research note to investors on Wednesday, January 8th. They set a neutral rating and a $131.00 price target on the stock. Nine equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company. Amgen has a consensus rating of Buy and a consensus price target of $123.04.
Amgen Inc. (NASDAQ:AMGN) traded up 1.84% on Tuesday, hitting $120.70. 4,345,807 shares of the company’s stock traded hands. Amgen Inc. has a 52-week low of $82.92 and a 52-week high of $124.46. The stock’s 50-day moving average is $115.8 and its 200-day moving average is $112.6. The company has a market cap of $91.023 billion and a P/E ratio of 18.80.
Amgen (NASDAQ:AMGN) last announced its earnings results on Tuesday, January 28th. The company reported $1.82 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.69 by $0.13. The company had revenue of $5.01 billion for the quarter, compared to the consensus estimate of $4.81 billion. During the same quarter last year, the company posted $1.40 earnings per share. Amgen’s revenue was up 13.1% compared to the same quarter last year. On average, analysts predict that Amgen Inc. will post $7.46 earnings per share for the current fiscal year.
Amgen Inc is a global biotechnology pioneer that discovers, develops, manufactures and delivers human therapeutics.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.